Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06397716 · ClinicalTrials.gov registry record · NA
Public Health Initiative on Alcohol Flushing
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT06397716: Completed NA study, sponsored by Stanford University.
NCT06397716 is a NA study that has completed, run by Stanford University. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06397716, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The overall aim of the study is to raise awareness of alcohol flushing and its health risks to the general population. The primary objective is to see if spreading awareness of the health risks of alcohol flushing and understanding personalized genotype information will lead to changes in alcohol consumption behavior.
Interventions
- GENETIC ALDH2 Genotyping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-04-25 |
| Est. Completion | 2024-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06397716
The ClinicalTrials.gov registry entry for NCT06397716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ALDH2 Genotyping is the first listed.
NCT06397716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06397716 about?
NCT06397716 is a clinical study titled "Public Health Initiative on Alcohol Flushing". The overall aim of the study is to raise awareness of alcohol flushing and its health risks to the general population. The primary objective is to see if spreading awareness of the health risks of alcohol flushing and understanding personalized genotype information will lead to changes in alcohol c...
What is the current status of trial NCT06397716?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2024-04-25. Estimated completion is 2024-04-25.
What interventions are being tested in trial NCT06397716?
The interventions under investigation include: ALDH2 Genotyping (GENETIC).
Who is sponsoring clinical trial NCT06397716?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.